An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies


Back Registration Programme Help desk
An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies Thursday, February 4, 2021 • SY09 • 4:15 PM > 5:15 PM • An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies • Live channel 2 The current HIV vaccine portfolio is both ambitious and filled with challenges. This session examines the most recent advances in prophylactic and therapeutic vaccine strategies designed to promote neutralization-independent mechanisms and elicit T cell responses with the potential to eradicate the virus. 4:15 PM • SY09.01 • Ad26 mosaic vaccine development program See abstract 4:25 PM • SY09.02 • Mechanistic insights into prime-boost vaccination See abstract 4:35 PM • SY09.03 • CMV-vectored vaccines for HIV prevention See abstract 4:45 PM • SY09.04 • Refocusing T cell responses with therapeutic vaccination strategies See abstract 4:55 PM • SY09.05 • Structural topology approaches to define T-cell epitopes See abstract 5:05 PM • SY09.06 • Live Q&A See abstract